1. K-RAS POINT MUTATIONS IN VARIOUS HISTOLOGICAL TYPES OF OVARIAN TUMORS. Issue 1 (1st March 2003) Authors: Semczuk, A.; Postawski, K.; Przadka, D.; Rozynska, K.; Wrobel, A.; Korobowicz, E. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P16INK4A INACTIVATION IN SPORADIC HUMAN ENDOMETRIAL CARCINOMAS. Issue 1 (1st March 2003) Authors: Semczuk, A.; Roessner, A.; Marzec, B.; Boltze, C.; Szczygielska, A.; Schneider-Stock, R. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients. (28th May 2015) Authors: Eggemann, H.; Ehricke, J.; Ignatov, T.; Fettke, F.; Semczuk, A.; Costa, S. D.; Ignatov, A. Journal: Cancer investigation Issue: Volume 33:Number 5(2015) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The significance of C3435T point mutation of the MDR1 gene in endometrial cancer. Issue 3 (1st May 2007) Authors: Mrozikiewicz, P. M.; Seremak-Mrozikiewicz, A.; Semczuk, A.; Landt, O.; Breborowicz, G. H.; Drews, K. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 3(2007) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗